The relationship between mouthrinse matrix metalloproteinases (MMP-1, 8, 13) and albumin levels with the degree of oral mucositis in allogeneic stem cell transplant patients

Bone Marrow Transplantation

Volumn 36, Issue 1, 2005, Pages 33-38

  Shoval, I ^a   Kushner, J A ^a   Sukhu, B ^b   Wood, R ^a   Kiss, T ^c   Lawrence, H P ^a   Tenenbaum, H C ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^d Faculty of Medicine   (Canada)

Author keywords

Albumin; Matrix metalloproteinases; Oral mucositis; Stem cell transplant

Indexed keywords

ALBUMIN; COLLAGENASE; COLLAGENASE 3; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; DISEASE SEVERITY; ENZYME ASSAY; HUMAN; LEUKEMIA; MOUTH HYGIENE; MOUTH LESION; MUCOSA INFLAMMATION; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; SALIVA ANALYSIS; SCORING SYSTEM;

EID: 21744435939     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704999     Document Type: Article

References (33)

1. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998; 34: 39-43.
2. Thomas ED, Blume KG, Forman SJ. Hematopoietic Cell Transplantation, 2nd edn Blackwell Science Inc.: Malden, MA, USA, 1999, pp 751-763.
3. National Cancer Institute Monographs. Consensus development conference on oral complications of cancer therapies: diagnosis, prevention and treatment. Bethesda: Natl Instit Health 1990, 9.
4. Biron P, Sebban C, Gourmet R et al. Research controversies in management of oral mucositis. Support Care Cancer 2000; 8: 68-71.
5. Shapiro TW, Davison DB, Rust DM. A Clinical Guide - Introduction to Stem Cell and Bone Marrow Transplantation. Jones and Bartlett Publishers Inc.: Boston, MA, 1997, pp 62-69.
6. Epstein JB, Schubert MM. Oral mucositis in myelosuppressive cancer therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 273-276.
7. Epstein JB, Stevenson-Moore P, Jackson S et al. Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse. Int J Radiat Oncol Biol Phys 1989; 16: 1571-1575.
8. Karthaus M, Rosenthal C, Ganser A. Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis - are there new strategies? Bone Marrow Transplant 1999; 24: 1095-1108.
9. Woo SB, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993; 72: 1612-1617.
10. Uitto VJ, Suomalainen K, Sorsa T. Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodontal Res 1990; 25: 135-142.
11. Mattson T. Oral side effects of bone marrow transplantation. Thesis 1991.
12. Wingard JR. Oral complications of cancer therapies. Infectious and noninfectious systemic consequences. NCI Monogr 1990; 9: 21-26.
13. McGuire DB, Yeager KA, Dudley WN et al. Acute oral pain and mucositis in bone marrow transplant and leukemia patients: data from a pilot study. Cancer Nurs 1998; 21: 385-393.
14. Plevova P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncol 1999; 35: 453-470.
15. Kostler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 2001; 51: 290-315.
16. Coda BA, O'Sullivan B, Donaldson G et al. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 1997; 72: 333-346.
17. Sonis ST, Elting LS, Keefe D et al. Perspectives on cancer therapy-induced mucosal injury. Cancer 2004; 100: S9 1995-2025.
18. Parks WC, Mecham RP. In: Mecham RP (ed.). Matrix Metalloproteinases. Academic Press: San Diego, California, USA, 1998, pp 1-13.
19. Gangbar S, Overall CM, McCulloch CA, Sodek J. Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis. J Periodontal Res 1990; 25: 257-267.
20. Lee W, Aitken S, Sodek J, McCulloch CA. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodontal Res 1995; 30: 23-33.
21. Romanelli R, Mancini S, Laschinger C et al. Activation of neutrophil collagenase in periodontitis. Infect Immun 1999; 67: 2319-2326.
22. Bhide VM, Smith L, Overall CM et al. Use of a fluorogenic septapeptide matrix metalloproteinase assay to assess responses to periodontal treatment. J Periodontol 2000; 71: 690-700.
23. Lee W, Aitken S, Kulkarni G et al. Collagenase activity in recurrent periodontitis: relationship to disease progression and doxycycline therapy. J Periodontal Res 1991; 26: 479-485.
24. Mancini S, Romanelli R, Laschinger CA et al. Assessment of a novel screening test for neutrophil collagenase activity in the diagnosis of periodontal diseases. J Periodontol 1999; 70: 1292-1302.
25. Izutsu KT, Truelove EL, Bleyer WA et al. Whole saliva albumin as an indicator of stomatitis in cancer therapy patients. Cancer 1981; 48: 1450-1454.
26. Sonis ST, Eilers JP, Epstein JB et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999; 85: 2103-2113.
27. Sonis ST, Oster G, Fuchs H et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001; 19: 2201-2205.
28. McCulloch CA. Host enzymes in gingival cervicular fluid as diagnostic indicators of periodontitis. J Clin Periodontol 1994; 21: 497-506.
29. Dahan M, Nawrocki B, Elkaim R et al. Expression of matrix metalloproteinases in healthy and diseased human gingiva. J Clin Periodontol 2001; 28: 128-136.
30. Golub LM, Lee HM, Greenwald RA et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival cervicular fluid during adult periodontitis. Inflamm Res 1997; 46: 310-319.
31. Golub LM, McNamara TF, Ryan ME et al. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001; 28: 146-156.
32. Collin HL, Sorsa T, Meurman JH et al. Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus. J Periodontal Res 2000; 35: 259-265.
33. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth 2000; 85: 599-610.